Evidence map›Paper›PMID 22442278›Full record

ArticleThe Journal of clinical endocrinology and metabolism2012

IOM committee members respond to Endocrine Society vitamin D guideline.

Clifford J Rosen, Steven A Abrams, John F Aloia, Patsy M Brannon, Steven K Clinton, Ramon A Durazo-Arvizu, J Christopher Gallagher, Richard L Gallo, Glenville Jones, Christopher S Kovacs and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 277 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 10 pooled it
36.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 10 syntheses or guidelines pooled it, 579 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Vitamin D for the management of multiple sclerosis.The Cochrane database of systematic reviews · 2018
    Pooled it
  8. Guideline
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Daily vitamin DEuropean journal of nutrition · 2021
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Clifford J RosenMaine Medical Center Research Institute, 81 Research Drive, Scarborough, Maine 04074, USA. crofen@gmail.com
Steven A Abrams
John F Aloia
Patsy M Brannon
Steven K Clinton
Ramon A Durazo-Arvizu
J Christopher Gallagher
Richard L Gallo
Glenville Jones
Christopher S Kovacs
JoAnn E Manson
Susan T Mayne
A Catharine Ross
Sue A Shapses
Christine L Taylor
Stony Brook University Hospital · USCornell University · USMaine Medical Center Research Institute · USNational Institutes of Health · US

Funding

Molecular Regulation of LRAT and CYP26 in Lung and LiverR01CA090214 · NCI · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI ROSS, A. CATHARINE · 2001 to 2012
$2.6M
NCI NIH HHS R01 CA090214
6 · The paper itself

Abstract

In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.

Indexed as

Health PromotionNutritional RequirementsPractice Guidelines as Topic25-Hydroxyvitamin D 2Age FactorsCalcifediolCalcium, DietaryEndocrinologyFemaleHumansIntestinal AbsorptionLactationMaleNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine DivisionParathyroid HormonePregnancy25-Hydroxyvitamin D 2CalcifediolCalcium, DietaryParathyroid HormonePTH protein, humanVitamin D

Identifiers

PMID22442278
PMCPMC5393439
OpenAlexW2116841061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.